Search Results - "KILIÇKAP, Saadettin"

Critical Role of Ga–68 DOTATATE PET-CT in a Patient with Neuroendocrine Tumor and Second Primary Cancer by TELLİ, Tuğçe, TUNCEL, Murat, KILIÇKAP, Saadettin

“…A 70-year-old female with the diagnosis of the metastatic neuroendocrine tumor was referred to our clinic with new abdominal lymph nodes in computed tomography…”
Get full text

Evaluation of risk factors for the recurrence of colorectal polyps and colorectal cancer by Ateş, Öztürk, Sivri, Bülent, Kılıçkap, Saadettin

“…Background/aim: Colorectal adenomatous polyps are precursors of colorectal cancer (CRC), which can be prevented with surveillance colonoscopy. This study aimed…”
Get full text

A Case of Multifocal Skin Metastases from Lung Cancer Presenting with Vasculitic-type Cutaneous Nodule by Babacan, Nalan Akgul, Kiliçkap, Saadettin, Sene, Soner, Kacan, Turgut, Yucel, Birsen, Eren, Mehmet Fuat, Cihan, Sener

“…Although cutaneous metastasis occurs usually at the terminal stage of the disease, it may be rarely concurrent with the diagnosis and may also present as the…”
Get full text

Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer by Tuncel, Murat, Kılıçkap, Saadettin, Süslü, Nilda

“…Purpose Medullary thyroid cancer (MTC) arises from neuroendocrine C cells of the thyroid. There is no single diagnostic imaging method that can reveal all MTC…”
Get full text

Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients by Bozkurt, Mehmet, Eldem, Gonca, Bozbulut, Utku Burak, Bozkurt, Murat Fani, Kılıçkap, Saadettin, Peynircioğlu, Bora, Çil, Barbaros, Lay Ergün, Eser, Volkan-Salanci, Bilge

“…Objective The aim of this study was to assess the early therapy response in patients with unresectable CCA who received Y-90 microsphere therapy for CCA and…”
Get full text

Sunitinib-Induced Microangiopathic Hemolytic Anemia: A Case Report by Korkmaz, Serdal, Kilickap, Saadettin, Terzi, Hatice, Sencan, Mehmet

Get full text

Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy by Kandemir, Esin Aysel, Bayraktar-Ekincioglu, Aygin, Kilickap, Saadettin

“…Purpose Cancer-associated venous thromboembolism (VTE) can cause many unfavorable health outcomes. Many institutions have published guidelines, but…”
Get full text

Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study by Aras, Elif, Bayraktar-Ekincioglu, Aygin, Kilickap, Saadettin

“…Purpose The guidelines suggest using granulocyte-colony stimulating factor (G-CSF) for febrile neutropenia (FN) as prophylaxis in chemotherapy protocols with…”
Get full text

Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma by Tural, Deniz, Selçukbiricik, Fatih, Ölmez, Ömer Fatih, Sümbül, Ahmet Taner, Erman, Mustafa, Coşkun, Hasan Şenol, Artaç, Mehmet, Kılıçkap, Saadettin

“…Background Atezolizumab (ATZ) has demonstrated antitumor activity in previous studies in patients with metastatic platinum-resistant urothelial carcinoma…”
Get full text

Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature by Arslan, Cağatay, Kiliçkap, Saadettin, Yalçin, Suayib

“…The risk of malignancy in transplant patients is higher than in the general population. The risk is increased mostly due to immune alteration and viral…”
Get full text

Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report by Taban, Hakan, Guven, Deniz Can, Kılıçkap, Saadettin

“…Crizotinib and entrectinib are approved tyrosine kinase inhibitors by the FDA to treat advanced-stage ROS1-positive non-small cell lung cancer (NSCLC)…”
Get full text

Oxaliplatin and ototoxicity: is it really safe for hearing? by Yüce, Salim, Seker, Mehmet Metin, Koç, Sema, Uysal, Ismail Onder, Kaçan, Turgut, Doğan, Mehtap, Doğan, Mansur, Babacan, Nalan Akgül, Kiliçkap, Saadettin

“…Oxaliplatin is an effective and widely used chemotherapeutic agent in the treatment of many solid tumors. The most common side effects are peripheral…”
Get full text

Oncologists’ attitudes towards prophylaxis of cancer associated venous thromboembolism: A prospective, descriptive study by Kandemir, Esin Aysel, Bayraktar-Ekincioglu, Aygin, Kilickap, Saadettin

“…Introduction Cancer-associated venous thromboembolism creates a big burden on both patients and healthcare systems. Clinical guidelines have a consensus on the…”
Get full text

Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19 by Guven, Deniz Can, Sahin, Taha Koray, Aktepe, Oktay Halit, Yildirim, Hasan Cagri, Aksoy, Sercan, Kilickap, Saadettin

“…Coronavirus disease 2019 (COVID-19) is expected to significantly affect cancer patients due to adverse outcomes with COVID-19 and disruptions in cancer care…”
Get full text

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors by Yücel, Kadriye Bir, Yekedüz, Emre, Karakaya, Serdar, Tural, Deniz, Ertürk, İsmail, Erol, Cihan, Ercelep, Özlem, Öztaş, Nihan Şentürk, Arslan, Çağatay, Uçar, Gökhan, Küçükarda, Ahmet, Sever, Özlem Nuray, Kılıçkap, Saadettin, Can, Orçun, Yazgan, Satı Coşkun, Öksüzoğlu, Berna, Karadurmuş, Nuri, Şendur, Mehmet Ali, Ürün, Yüksel

“…This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal…”
Get full text

The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients by Ozdemir, Nesligul, Bayraktar-Ekincioglu, Aygin, Kilickap, Saadettin

Get full text

Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review by Guven, Deniz C, Sahin, Taha K, Kilickap, Saadettin, Uckun, Fatih M

“…After the results of phase III vaccine studies became available, the leading oncology societies recommended two doses of COVID-19 vaccination to all patients…”
Get full text

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR) by Ramos-Casals, Manuel, Maria, Alexandre, Suárez-Almazor, María E, Lambotte, Olivier, Fisher, Benjamin A, Hernández-Molina, Gabriela, Guilpain, Philippe, Pundole, Xerxes, Flores-Chávez, Alejandra, Baldini, Chiara, Bingham Iii, Clifton O, Brito-Zerón, Pilar, Gottenberg, Jacques-Eric, Kostine, Marie, Radstake, Timothy R D, Schaeverbeke, Thierry, Schulze-Koops, Hendrik, Calabrese, Leonard, Khamashta, Munther A, Mariette, Xavier

“…To analyse the worldwide occurrence of sicca/Sjögren's (SS) syndrome associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer. The…”
Get full text

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study by Yekedüz, Emre, Tural, Deniz, Ertürk, İsmail, Karakaya, Serdar, Erol, Cihan, Ercelep, Özlem, Arslan, Çağatay, Sever, Özlem Nuray, Kılıçkap, Saadettin, Şentürk Öztaş, Nihan, Küçükarda, Ahmet, Can, Orçun, Öksüzoğlu, Berna, Şendur, Mehmet Ali, Karadurmuş, Nuri, Ürün, Yüksel

“…Background Pan-immune-inflammation value (PIV) is an easily accessible immune marker based on peripheral blood to estimate prognosis in patients with cancer…”
Get full text

The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients by Özdede, Murat, Taban, Hakan, Akman, Orkun, Önder, Sevgen, Kılıçkap, Saadettin

“…The majority of lung cancers belong to the non-small-cell lung cancer (NSCLC) category, which is linked to a high mortality rate despite significant progress…”
Get full text